Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,317,589 papers from all fields of science
Search
Sign In
Create Free Account
Novoseven
Known as:
Novo Seven
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (3)
Factor VIIa
factor VII
recombinant FVIIa
eptacog alfa activated 0.001 MG Injection [Novoseven]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety and Efficacy of Orphan Nano Drugs to Treat High Cholesterol and Related Conditions and to PreventCardiovascular Disease Under…
A. Heidari
2017
Corpus ID: 80331807
Orphan Nano drugs such as Rituxan, Revlimid, Soliris, Afinitor, Tasigna, Velcade, Avonex, Alimta, Yervoy, Sprycel, Rebif…
Expand
Highly Cited
2005
Highly Cited
2005
Recombinant factor VIIa (NovoSeven®) as a hemostatic agent after surgery for congenital heart disease
Y. Razon
,
E. Erez
,
+4 authors
O. Dagan
Paediatric anaesthesia
2005
Corpus ID: 1646164
Background : Postoperative bleeding and blood product requirements can be substantial in children undergoing open‐heart surgery…
Expand
2004
2004
Factor VII deficiency and its treatment in delivery with recombinant factor VII.
B. Pehlivanov
,
N. Milchev
,
G. Kroumov
European Journal of Obstetrics, Gynecology, and…
2004
Corpus ID: 44346939
Review
2003
Review
2003
Update on Novo Nordisk's clinical trial programme on NovoSeven®
A. Dejgaard
Blood Coagulation and Fibrinolysis
2003
Corpus ID: 33057494
Recombinant coagulation factor VIIa (rFVIIa; Novoseven®, Novo Nordisk A/S, Bagsvaerd, Denmark) is registered in most regions of…
Expand
2002
2002
Successful Use of Recombinant Activated Factor VII (Novoseven®) in Controlling Severe Intra-Abdominal Bleeding after Liver Needle Biopsy
R. Hoffman
,
A. Mahajana
,
P. Agmon
,
Y. Barach
,
B. Brenner
Thrombosis and Haemostasis
2002
Corpus ID: 38511673
Successful Use of Recombinant Activated Factor VII (Novoseven®) in Controlling Severe Intra-Abdominal Bleeding after Liver Needle…
Expand
Highly Cited
2001
Highly Cited
2001
Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor.
M. Elg
,
S. Carlsson
,
D. Gustafsson
Thrombosis Research
2001
Corpus ID: 24438828
Review
2001
Review
2001
Recombinant factor VIIa (Novoseven) as a hemostatic agent.
U. Hedner
Seminars in hematology (Print)
2001
Corpus ID: 32677570
Recombinant activated factor VII (rFVIIa; NovoSeven, Novo Nordisk, Denmark) induces hemostasis in life- and limb-threatening…
Expand
Highly Cited
2000
Highly Cited
2000
Recombinant activated factor VII (NovoSeven®) treatment of platelet‐related bleeding disorders
M. Poon
,
R. d’Oiron
2000
Corpus ID: 58447656
&NA; Recombinant activated factor VII (rFVIIa; NovoSeven®, Novo Nordisk A/S, Bagsvaerd, Denmark), used extensively for the…
Expand
2000
2000
NovoSeven® in immune tolerance therapy
H. Brackmann
,
E. Effenberger
,
L. Hess
,
R. Schwaab
,
J. Oldenburg
Blood Coagulation and Fibrinolysis
2000
Corpus ID: 36097917
&NA; The development of inhibitors in haemophilia patients is one of the most serious challenges to effective treatment. The…
Expand
2000
2000
Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases
Tagariello
,
De Biasi
,
+4 authors
Traldi
Haemophilia
2000
Corpus ID: 39912788
In this report we describe our experience of total hip replacement in two patients with severe haemophilia A and high titres of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE